- Home
- TRVI vs AXGN Comparison
TRVI vs AXGN Comparison
Compare TRVI & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- AXGN
- Stock Information
- Founded
- TRVI 2011
- AXGN N/A
- Country
- TRVI United States
- AXGN United States
- Employees
- TRVI N/A
- AXGN N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TRVI Health Care
- AXGN Health Care
- Exchange
- TRVI Nasdaq
- AXGN Nasdaq
- Market Cap
- TRVI 629.8M
- AXGN 538.3M
- IPO Year
- TRVI 2019
- AXGN N/A
- Fundamental
- Price
- TRVI $5.83
- AXGN $11.09
- Analyst Decision
- TRVI Strong Buy
- AXGN Strong Buy
- Analyst Count
- TRVI 8
- AXGN 6
- Target Price
- TRVI $19.31
- AXGN $23.83
- AVG Volume (30 Days)
- TRVI 1.0M
- AXGN 749.9K
- Earning Date
- TRVI 05-08-2025
- AXGN 05-08-2025
- Dividend Yield
- TRVI N/A
- AXGN N/A
- EPS Growth
- TRVI N/A
- AXGN N/A
- EPS
- TRVI N/A
- AXGN N/A
- Revenue
- TRVI N/A
- AXGN $194,520,000.00
- Revenue This Year
- TRVI N/A
- AXGN $18.02
- Revenue Next Year
- TRVI N/A
- AXGN $16.25
- P/E Ratio
- TRVI N/A
- AXGN N/A
- Revenue Growth
- TRVI N/A
- AXGN 18.81
- 52 Week Low
- TRVI $2.30
- AXGN $6.57
- 52 Week High
- TRVI $7.39
- AXGN $21.00
- Technical
- Relative Strength Index (RSI)
- TRVI 56.14
- AXGN 28.05
- Support Level
- TRVI $6.08
- AXGN $10.74
- Resistance Level
- TRVI $6.47
- AXGN $11.58
- Average True Range (ATR)
- TRVI 0.39
- AXGN 0.55
- MACD
- TRVI -0.00
- AXGN 0.04
- Stochastic Oscillator
- TRVI 45.06
- AXGN 14.67
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.